January, 2017

VBL Therapeutics Announces Publication of Research on a Potential Novel Immuno-Oncology Target

TEL AVIV, Israel, Jan. 31, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (NASDAQ:VBLT), announced today ...

NANOBIOTIX : 2016 review and 2017 anticipated milestones

   Nanobiotix: 2016 review and 2017 anticipated milestones Paris, France and Cambridge, Massachusetts, USA, January ...

Dems force delay in vote for HHS secretary

Democrats on the Senate Finance Committee forced a delay action that would have moved ...

As-needed anticoagulation for intermittent Afib raises concerns

AT AF SYMPOSIUM 2017 ORLANDO (FRONTLINE MEDICAL NEWS) – A pilot study that suggested ...

Stroke rates high when catheter ablation of AF fails

AT THE AF SYMPOSIUM 2017 ORLANDO (FRONTLINE MEDICAL NEWS) – In patients with atrial ...